Holds one active US DMF for nepafenac, filing since 2024. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 16 markets.
Holds one active US DMF for nepafenac, filing since 2024. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 16 markets.
Holds one active US DMF for nepafenac, filing since 2014. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.
Holds one active US DMF for nepafenac, filing since 2004. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for nepafenac, filing since 2009. Its 2024 FDA inspection closed as NAI.
Holds 2 active US DMFs for nepafenac, filing since 2016. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for nepafenac, filing since 2009.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for nepafenac and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2025 | $13000.00 | 7 |
| 2024 | $12323.22 | 8 |
| 2023 | $16241.54 | 7 |
| 2022 | $18892.49 | 12 |
US dollars per kilogram, customs export unit values.